SCHEMBL4163000

SCHEMBL4163000

O=C[C@H](OC(=O)c1cc(O)c(O)c(O)c1)[C@@H](OC(=O)c1cc(O)c(O)c(O)c1)[C@H](OC(=O)c1cc(O)c(O)c(O)c1)[C@@H](CO)OC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 8/20 0.46
PRKCA P17252 1/20 0.39
POLB P06746 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
NFKB1 P19838 1/20 0.38
XDH P47989 1/20 0.38
GFER P55789 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
FUT7 Q11130 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN11 Q06124 1/20 0.38
ESR1 P03372 1/20 0.35
POLA1 P09884 1/20 0.34
ANTXR2 P58335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28444407 1.00 SERPINE1 (0.46) SERPINE1PRKCAPOLBKDM4ELMNA
SCHEMBL6672368 0.87 SERPINE1 (0.43) SERPINE1POLBKDM4ELMNAGAA
SCHEMBL391922 0.87 SERPINE1 (0.57) SERPINE1PTPN2PTPN1PTPN11ESR1
SCHEMBL28031026 0.87 SERPINE1 (0.57) SERPINE1PTPN2PTPN1PTPN11ESR1
SCHEMBL28447050 0.86 SERPINE1 (0.46) SERPINE1POLBKDM4ELMNAGAA
SCHEMBL1137255 0.86 SERPINE1 (0.46) SERPINE1POLBKDM4ELMNAGAA
Water SCHEMBL23067557 0.86 SERPINE1 (0.56) SERPINE1PTPN2PTPN1PTPN11ESR1
SCHEMBL15142163 0.83 SERPINE1 (0.44) SERPINE1PRKCAPOLBKDM4ELMNA
SCHEMBL28446906 0.83 SERPINE1 (0.44) SERPINE1PRKCAPOLBKDM4ELMNA
SCHEMBL5664340 0.83 SERPINE1 (0.44) SERPINE1PRKCAPOLBKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116139172-B Effective fraction of gallnut, preparation method and application thereof 石河子大学 2024-08-06 CN claimed
CN-112375803-B Screening method of anti-inflammatory active component ethyl gallate in gallnut and application thereof 石河子大学 2024-05-07 CN claimed
CN-116139172-A Effective fraction of gallnut, preparation method and application thereof 石河子大学 2023-05-23 CN claimed
CN-110652505-B Application of Trapa acornis nakai shell polyphenol extract in preparation of medicine for resisting HER-2 over-expression type breast cancer 嘉兴学院 2022-05-31 CN claimed
CN-110632230-B Method for detecting multiple small molecular chemical components in Xuebijing injection 中国科学院上海药物研究所 2021-07-27 CN claimed
CN-110652529-B Application of Trapa acornis nakai shell polyphenol extract in preparation of drug for resisting triple negative breast cancer 嘉兴学院 2021-06-08 CN claimed
CN-111624269-A Method for screening drug effect substances for treating adenomyosis in cassia twig and poria cocos pills 山东中医药大学附属医院 2020-09-04 CN claimed
CN-110437289-B Preparation method of tetragalloyl glucose 广东省农业科学院茶叶研究所 2020-07-07 CN claimed
CN-110652505-A Application of Trapa acornis nakai shell polyphenol extract in preparation of medicine for resisting HER-2 over-expression type breast cancer 嘉兴学院 2020-01-07 CN claimed
CN-110652529-A Application of Trapa acornis nakai shell polyphenol extract in preparation of drug for resisting triple negative breast cancer 嘉兴学院 2020-01-07 CN claimed
CN-110643308-A Adhesive for protective film, protective film for photomask and method for manufacturing same 三星电子株式会社 2020-01-03 CN claimed
CN-110632230-A Method for detecting multiple small molecular chemical components in Xuebijing injection 中国科学院上海药物研究所 2019-12-31 CN claimed
US-20190390090-A1 ADHESIVE FOR PELLICLE, PELLICLE FOR PHOTO MASK AND METHOD FOR MANUFACTURING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-12-26 US claimed
EP-1545554-A4 METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS UNIV OHIO (US) 2006-06-14 EP claimed
US-20060058243-A1 Methods and compositions for treating diabetes mellitis OHIO UNIVERSITY 2006-03-16 US claimed
EP-1545554-A1 METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS Ohio University (US) 2005-06-29 EP claimed
WO-2004009094-A1 METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS OHIO UNIVERSITY (US) 2004-01-29 WO claimed
JP-61100517-A None JP disclosed
US-5159069-A Viricide, enzyme inhibitor YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-10-27 US disclosed
JP-S61100517-A NOVEL AGENT FOR DENTAL CARIES NISSAN CHEM IND LTD 1986-05-19 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058243-A1 Methods and compositions for treating diabetes mellitis IAPP, GCG, MTPN SERPINE1 196/4885PRKCA 3208/4885POLB 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.